Cathay Biotech Inc.

SHSE:688065 Stock Report

Market Cap: CN¥21.6b

Cathay Biotech Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Xiucai Liu

Chief executive officer

CN¥4.1m

Total compensation

CEO salary percentagen/a
CEO tenure5.4yrs
CEO ownershipn/a
Management average tenure5.4yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

Does Cathay Biotech (SHSE:688065) Have A Healthy Balance Sheet?

Jan 09
Does Cathay Biotech (SHSE:688065) Have A Healthy Balance Sheet?

Cathay Biotech's (SHSE:688065) Profits Appear To Have Quality Issues

Nov 07
Cathay Biotech's (SHSE:688065) Profits Appear To Have Quality Issues

What Cathay Biotech Inc.'s (SHSE:688065) 38% Share Price Gain Is Not Telling You

Oct 22
What Cathay Biotech Inc.'s (SHSE:688065) 38% Share Price Gain Is Not Telling You

Cathay Biotech (SHSE:688065) Could Be Struggling To Allocate Capital

Oct 20
Cathay Biotech (SHSE:688065) Could Be Struggling To Allocate Capital

Cathay Biotech (SHSE:688065) Seems To Use Debt Quite Sensibly

Sep 29
Cathay Biotech (SHSE:688065) Seems To Use Debt Quite Sensibly

Cathay Biotech Inc.'s (SHSE:688065) Share Price Not Quite Adding Up

Sep 07
Cathay Biotech Inc.'s (SHSE:688065) Share Price Not Quite Adding Up

There Are Reasons To Feel Uneasy About Cathay Biotech's (SHSE:688065) Returns On Capital

Jun 19
There Are Reasons To Feel Uneasy About Cathay Biotech's (SHSE:688065) Returns On Capital

Cathay Biotech (SHSE:688065) Has A Somewhat Strained Balance Sheet

May 28
Cathay Biotech (SHSE:688065) Has A Somewhat Strained Balance Sheet

What Cathay Biotech Inc.'s (SHSE:688065) 27% Share Price Gain Is Not Telling You

May 07
What Cathay Biotech Inc.'s (SHSE:688065) 27% Share Price Gain Is Not Telling You

We Think That There Are More Issues For Cathay Biotech (SHSE:688065) Than Just Sluggish Earnings

May 06
We Think That There Are More Issues For Cathay Biotech (SHSE:688065) Than Just Sluggish Earnings

CEO

Xiucai Liu (67 yo)

5.4yrs

Tenure

CN¥4,065,600

Compensation

Dr. Xiucai Liu has been Chairman of Cathay Industrial Biotech, Ltd. (formerly known as Cathay Biotech Inc.) since April 2006 and serves as its Chief Executive Officer. Dr. Liu serves as Chairman and Chief...

Leadership Team

NamePositionTenureCompensationOwnership
Xiucai Liu
Chairman & CEO5.4yrsCN¥4.07mno data
Chen Yang
VP, Core Technician & COO3yrsCN¥1.00mno data
Huiqing Zang
Vice Presidentno dataCN¥1.06mno data
Yijun Du
Vice President5.4yrsCN¥1.26mno data
Hong Guang Zhang
Vice President5.4yrsCN¥1.05m0.0010%
CN¥ 222.7k

5.4yrs

Average Tenure

56yo

Average Age

Experienced Management: 688065's management team is seasoned and experienced (5.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Xiucai Liu
Chairman & CEO5.4yrsCN¥4.07mno data
Huiqing Zang
Vice President5.4yrsCN¥1.06mno data
William Robert Keller
Director5.4yrsCN¥535.60kno data
Faqin Lu
Independent Director5.4yrsCN¥100.00kno data
Bing Zhang
Independent Director5.4yrsCN¥100.00kno data
Guohua Zhang
Chairman of the Supervisory Board5.4yrsno datano data
Li Pan
Supervisor5.4yrsno datano data
Xin Liu
Supervisor5.4yrsno datano data
Xiang Yang Wu
Independent Director2.4yrsCN¥100.00kno data

5.4yrs

Average Tenure

54yo

Average Age

Experienced Board: 688065's board of directors are considered experienced (5.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 03:53
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cathay Biotech Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Junjun ZhuHaitong International Research Limited